AU2002224109A1 - Excretion accelerator for accumulative chlorine compound - Google Patents

Excretion accelerator for accumulative chlorine compound

Info

Publication number
AU2002224109A1
AU2002224109A1 AU2002224109A AU2410902A AU2002224109A1 AU 2002224109 A1 AU2002224109 A1 AU 2002224109A1 AU 2002224109 A AU2002224109 A AU 2002224109A AU 2410902 A AU2410902 A AU 2410902A AU 2002224109 A1 AU2002224109 A1 AU 2002224109A1
Authority
AU
Australia
Prior art keywords
chlorine compound
excretion
accumulative chlorine
accumulative
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224109A
Inventor
Shigekazu Nakajima
Kazuo Suzuki
Shinji Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2002224109A1 publication Critical patent/AU2002224109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Glass Compositions (AREA)

Abstract

An agent for promoting excretion of an accumulative chlorine compound comprising a pharmaceutically acceptable anion exchange resin, which is a novel agent that is for promoting the excretion of an accumulative chlorine compound and is capable of efficiently excreting residual chlorinated compounds including dioxins as typical examples.
AU2002224109A 2000-11-28 2001-11-27 Excretion accelerator for accumulative chlorine compound Abandoned AU2002224109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-361834 2000-11-28
JP2000361834 2000-11-28
PCT/JP2001/010310 WO2002043744A1 (en) 2000-11-28 2001-11-27 Excretion accelerator for accumulative chlorine compound

Publications (1)

Publication Number Publication Date
AU2002224109A1 true AU2002224109A1 (en) 2002-06-11

Family

ID=18833210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224109A Abandoned AU2002224109A1 (en) 2000-11-28 2001-11-27 Excretion accelerator for accumulative chlorine compound

Country Status (11)

Country Link
US (1) US8173114B2 (en)
EP (1) EP1358886B1 (en)
JP (1) JP4270540B2 (en)
KR (1) KR100782245B1 (en)
CN (1) CN1273144C (en)
AT (1) ATE473007T1 (en)
AU (1) AU2002224109A1 (en)
CA (1) CA2430123C (en)
DE (1) DE60142527D1 (en)
ES (1) ES2349093T3 (en)
WO (1) WO2002043744A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324519B (en) * 2001-07-30 2010-05-11 Mitsubishi Tanabe Pharma Corp Drugs for ameliorating postcibal hyperglycemia
DE102004007358B4 (en) * 2004-02-16 2017-10-12 Chiron As Congeners, chlorinated, brominated and / or iodinated fluorinated aromatic compounds containing two benzene rings in their basic structure, process for their preparation and their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60209523A (en) 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd Antilipemic agent
US5840339A (en) * 1991-07-30 1998-11-24 Kunin; Robert Blood cholesterol reducing pharmaceutical composition
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5414068A (en) 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
TW528597B (en) * 1996-03-05 2003-04-21 Mitsubishi Electric Corp Medicament for preventive and/or therapeutic treatment of hyperphosphatemia
EA004877B1 (en) * 1998-12-23 2004-08-26 Джи.Ди.Сирл Ллс Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core

Also Published As

Publication number Publication date
ES2349093T3 (en) 2010-12-27
US20040047834A1 (en) 2004-03-11
WO2002043744A1 (en) 2002-06-06
CN1514730A (en) 2004-07-21
US8173114B2 (en) 2012-05-08
CA2430123C (en) 2010-08-24
CN1273144C (en) 2006-09-06
KR100782245B1 (en) 2007-12-05
KR20030070025A (en) 2003-08-27
DE60142527D1 (en) 2010-08-19
ATE473007T1 (en) 2010-07-15
EP1358886B1 (en) 2010-07-07
EP1358886A4 (en) 2005-08-17
CA2430123A1 (en) 2002-06-06
JPWO2002043744A1 (en) 2004-04-02
JP4270540B2 (en) 2009-06-03
EP1358886A1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
AU1519100A (en) System for modifying the functionality of compiled computer code at run-time
AU2001295999A1 (en) Nateglinide-containing preparations
AU2002310976A1 (en) Tert. alkylphenoxy substituted polycyclic compounds
AU3877000A (en) Allyl compounds, compositions containing allyl compounds and processes for forming and curing polymer compositions
MXPA03004060A (en) Silica filled elastomeric compounds.
WO2001023362A3 (en) Rate-controlled particles
AU2001232513A1 (en) An industrial robot with an actuated brake system, which cooperate with the robot's control system
AU2002224109A1 (en) Excretion accelerator for accumulative chlorine compound
AU2001294673A1 (en) Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
SI1197223T1 (en)
AU2002230507A1 (en) Composition and method for making a fluoroelastomer
AU1247701A (en) Mpeg-4 video specific control packet for providing a customized set of coding tools
SI1619185T1 (en) 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
AU5523199A (en) Waste treatment by adding at least an alkaline reagent
AU2003217028A1 (en) Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
AU2002322452A1 (en) Halogenated antituberculosis agents
CA2438514A1 (en) Use of a material and a method for retaining polyhalogenated compounds
EP1260400A3 (en) Lid
AU2001276433A1 (en) Stabilising composition for halogenated polymers comprising a unsaturated heterocyclic compound
AU2003302395A1 (en) Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) ones used as herbicides
AU2002216220A1 (en) Amoxycillin pellets
AU2003208362A1 (en) Method for producing 1,2-dichloroethane by direct chlorination
AU5055999A (en) Anti-inflammatory compounds
WO2000075094A3 (en) Method for producing a halogenated acetophenone